A Phase 2, Randomized, Double-blind, Parallel Group, Placebo Controlled Study to Evaluate the Effect of Tezepelumab on Airway Inflammation in Adults with Inadequately Controlled Asthma on Inhaled Corticosteroids and at least one additional asthma control

Project: Other project

StatusActive
Effective start/end date2/6/192/5/21

Funding

  • AstraZeneca LP: $6,773.08